Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia Journal Article


Authors: Mato, A. R.; Woyach, J. A.; Brown, J. R.; Ghia, P.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; Shah, N. N.; Coombs, C. C.; Ujjani, C. S.; Fakhri, B.; Cheah, C. Y.; Patel, M. R.; Alencar, A. J.; Cohen, J. B.; Gerson, J. N.; Flinn, I. W.; Ma, S.; Jagadeesh, D.; Rhodes, J. M.; Hernandez‑Ilizaliturri, F.; Zinzani, P. L.; Seymour, J. F.; Balbas, M.; Nair, B.; Abada, P.; Wang, C.; Ruppert, A. S.; Wang, D.; Tsai, D. E.; Wierda, W. G.; Jurczak, W.
Article Title: Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia
Journal Title: New England Journal of Medicine
Volume: 389
Issue: 1
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2023-07-06
Start Page: 33
End Page: 44
Language: English
DOI: 10.1056/NEJMoa2300696
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 37407001
DOI/URL:
Notes: Accession Number: 164829324 -- Entry Date: In Process -- Revision Date: 20230717 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 0255562. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato